Literature DB >> 16477386

New oxo-bridged peroxotungsten complexes containing biogenic co-ligand as potent inhibitors of alkaline phosphatase activity.

Pankaj Hazarika1, Diganta Kalita, Swapnalee Sarmah, Nashreen S Islam.   

Abstract

Novel dinuclear peroxo complexes of tungsten with coordinated cystine of the type A(2)[W(2)O(3)(O(2))(4)(cystine)].4H(2)O, A = Na (1) or K (2) have been synthesized from the reaction of A(2)WO(4,)cysteine and 30% H(2)O(2)at pH 2.5. The synthesized compounds were characterized by elemental analysis, spectral and physico-chemical methods. The two W(VI) centres with side-on bound peroxo groups of the dinuclear complex species are bridged by an oxo group and a cystine ligand, formed from the oxidation of cysteine. Cystine occurring as zwitterion binds the metal centers of the complex ion through O(carboxylate) atoms leading to hepta co-ordination around each W(VI). The compounds exhibit high stability toward decomposition in solution of acidic as well as physiological pH and serve as weak substrates to catalase, undergoing degradation in presence of the enzyme at a rate much slower relative to H(2)O(2). The compounds efficiently oxidized GSH to GSSG, a reaction in which only two of the peroxide groups of the complex species were found to participate. The compounds induce strong inhibitory effect on alkaline phosphatase activity with a potency higher than that of the free cystine, tungstate, or peroxotungstate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16477386     DOI: 10.1007/s11010-005-9011-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  15 in total

1.  Tissue sulfhydryl groups.

Authors:  G L ELLMAN
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

Review 2.  The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds.

Authors:  Debbie C Crans; Jason J Smee; Ernestas Gaidamauskas; Luqin Yang
Journal:  Chem Rev       Date:  2004-02       Impact factor: 60.622

Review 3.  Synthetic analogues and reaction systems relevant to the molybdenum and tungsten oxotransferases.

Authors:  John H Enemark; J Jon A Cooney; Jun-Jieh Wang; R H Holm
Journal:  Chem Rev       Date:  2004-02       Impact factor: 60.622

4.  Anti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptase.

Authors:  P S Moore; C J Jones; N Mahmood; I G Evans; M Goff; R Cooper; A J Hay
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

5.  Catalase degrades diperoxovanadate and releases oxygen.

Authors:  H N Ravishankar; A V Rao; T Ramasarma
Journal:  Arch Biochem Biophys       Date:  1995-08-20       Impact factor: 4.013

6.  Peroxo heteroligand vanadates(V): synthesis, spectra-structure relationships, and stability toward decomposition.

Authors:  C Djordjevic; N Vuletic; M L Renslo; B C Puryear; R Alimard
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 7.  The chemistry of peroxovanadium compounds relevant to insulin mimesis.

Authors:  A Shaver; J B Ng; D A Hall; B I Posner
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

8.  Letter: Transition metal ion inhibition of enzyme-catalyzed phosphate ester displacement reactions.

Authors:  R L VanEtten; P P Waymack; D M Rehkop
Journal:  J Am Chem Soc       Date:  1974-10-16       Impact factor: 15.419

9.  The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats.

Authors:  A Shisheva; O Ikonomov; Y Shechter
Journal:  Endocrinology       Date:  1994-01       Impact factor: 4.736

10.  Permolybdate and pertungstate--potent stimulators of insulin effects in rat adipocytes: mechanism of action.

Authors:  J Li; G Elberg; D Gefel; Y Shechter
Journal:  Biochemistry       Date:  1995-05-09       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.